CT Automotive Group PLC (CTA) — Investment Research Note

Executive summary

CT Automotive is a UK-listed AIM small-cap that designs and manufactures bespoke automotive interior components (dashboard panels, kinematic assemblies) from low-cost bases in China, Mexico and Türkiye, selling to volume OEMs (Nissan, Ford, GM, VAG), premium brands (Bentley, Lamborghini) and EV players (Rivian) directly or via Tier 1s (Forvia, Marelli). Across the reviewed period the Group has moved from a $24.7m FY22 loss through a strong 2023 recovery to a third consecutive year of adjusted PBT improvement in FY25 ($9.5m, +20%) despite revenue declining 4% to $114.8m 2026-05 FY25 results, with gross margin expanding by ~1,900 bps over three years to 31%. The single most important valuation point is that the shares trade at ~2.6x FY25 adjusted PBT and ~5.7x reported earnings on a market cap of £24.3m — a genuinely low multiple — but the FY25 accounts contain a substantial retrospective restatement (FY24 adj PBT cut from $8.7m to $7.9m; net assets reduced by $5.0m) and H1 26 profit is guided "materially below" prior year, both of which meaningfully cap the confidence with which the cheap multiple can be underwritten.

Fair value estimate

• Fair value range: 42p – 60p per share (mid ~51p), implying a market cap range of £31m – £44m (mid ~£37m).
• Methodology: blended multiple of forward earnings — (i) 4.5x – 6.5x FY26E adjusted EBITDA of ~$15m (in line with guidance for "materially stronger H2") less net debt of ~$7.7m; and (ii) 5.5x – 8.0x FY26E adjusted PBT of ~$10m guided by management 2026-08 trading update. At $1.34/£, the 4.5x/6.5x EBITDA range gives an EV of $67m–$97m, equity of $60m–$90m, or £44m–£67m (60–91p). The PBT-based approach at 5.5x–8.0x on $10m adj PBT yields £41m–£60m equity, or 55–81p. I skew toward the lower end of both to reflect the accounting-quality overhang and cyclicality, giving a 42p – 60p range.
• vs latest disclosed market cap of £24.3m (33p), the mid case implies ~55% upside (range: +27% to +82%).

Sector context

• ICB Consumer Discretionary — Automobiles & Parts is the correct classification (auto interior components / Tier 2 supplier).
• Quality/growth/leverage profile is broadly in line with typical peers — asset-heavy Tier 2 auto supplier with cyclical demand, low-teens EBITDA margin, modest leverage. Gross margin (31%) is above the peer average due to the low-cost China/Mexico footprint, but scale is materially smaller and the balance sheet is weaker than large listed peers.
• Listed comparables: Autins Group (AUTG.L) and Carclo (CAR.L) on the UK side; larger reference points Forvia (EPA:FRVIA) and Marelli (as customer, currently in Chapter 11). None is a clean direct peer.

Investment thesis (3 bullets)

1. Genuine near-shoring / tariff-arbitrage story: Mexico facility, built out with $5.6m of FY25 capex, has attracted 15 new contract wins in FY25 worth $47m of annualised revenue when fully ramped, largely from customers relocating from China to secure USMCA benefits 2026-05 FY25 results; 2026-02 trading update. If those revenues layer in over 2026–28 without pricing concessions, FY27 revenue could exceed $140m against FY25's $114.8m.
2. Structural gross-margin expansion is real, not just mix: gross margin has moved 22% → 28% → 31% across FY23–FY25, driven by direct-labour reductions (–9.7% in FY25 vs FY24), automation of injection moulding (single AI-planning application saved ~$1m in FY24) and the shift from Shenzhen to lower-cost Ganzhou 2025-05 FY24 results; 2026-05 FY25 results. Management is guiding to further improvement in FY26 as the Mexico ramp normalises.
3. Valuation cushion is unusually large for the operating profile: at 33p the shares trade at ~2.6x FY25 adjusted PBT of $9.5m and ~5.7x reported basic EPS of 11.4c, with net debt of just 0.5x EBITDA and a covenant FCCR of 1.83x (vs 1.5x minimum) 2026-05 FY25 results. Even if FY26 delivers only the FY25 outturn again, the shares would be cheap on any conventional multiple.

Key risks (3 bullets)

1. Earnings-quality and controls history: FY25 results contain retrospective restatements totalling a $0.8m FY24 PBT reduction and a $5.0m net-asset write-down, spanning five separate categories (revenue recognition, misclassified customer overpayment, unsupported consolidation adjustment, IFRS 16 errors, and China statutory adjustments). Errors go back to 2016. External expert (Rebus Partners) had to review one of them. CFO resigned in early 2026, auditor changed from BDO to MHA, and the finance function is currently run by the "Group Head of Finance" rather than a CFO 2026-05 FY25 results. This is a meaningful red flag on a stock this small.
2. H1 26 profit warning already banked: the 4 August 2026 trading statement guides H1 26 PBT "materially below" the prior-year comparative on unplanned Mexico ramp costs and freight inflation. The company still guides to consensus for FY26 ($123.5m revenue, $10.2m adj PBT) but this now requires a very strong H2 rebound. Any further miss would compound investor scepticism 2026-08 trading update.
3. Customer concentration and cyclicality: three customers = 77% of FY25 revenue (Forvia at $51.7m/45%; the second-largest at $23.8m/21%; the third at $12.6m/11%). Marelli, an important Tier 1, is in Chapter 11 since June 2025 2026-05 FY25 results. Auto demand is deeply cyclical, and the OEM destocking cycle of FY24 shows how quickly revenue can drop.

Operating leverage

CT Automotive is a mid-leverage industrial: the gross margin has moved from 12% → 22% → 28% → 31% across FY22–FY25 on broadly flat-to-declining revenue, which demonstrates material operating leverage on the cost base of an existing plant. However, the absolute gross margin at 31% is characteristic of a specialised industrial rather than a capital-light platform. Management explicitly states in the FY24 and FY25 outlook that "our facilities retain additional capacity to support future growth without requiring significant additional capital investment" and that "our operations are positioned to accommodate increased production without additional cost pushing profitability directly to the bottom line" 2025-05 FY24 results; 2026-02 trading update. On the FY25 base ($114.8m revenue, $14.8m EBITDA), a 15–20% revenue beat (say +$20m) at incremental gross margin of ~40% (implied by the recent margin expansion at flat volume) would deliver ~$8m of extra gross profit against a semi-fixed indirect cost base — plausibly ~50% incremental to adjusted EBITDA. This is real but not extreme leverage — closer to 55–65 on the scoring scale than to the software-like 80+. The one meaningful "inflection" candidate is the Mexico facility, which the FY24 statement claims "can accommodate three times its current revenue without requiring additional investment in property or overhead" — if this is even approximately correct, Mexico could be a step-function contributor to margin from FY27.

Value-trap signals

• Repeated prior-period accounting restatements (five separate categories in FY25 relating to FY21–FY24) with implications for the reliability of historical earnings.
• Recent H1 26 profit shortfall ("materially below" prior year) coming just months after the FY25 results — pattern of near-term slippage.
• CFO resignation early 2026 with an interim finance leadership structure in place; auditor changed (BDO → MHA).
• Related-party unsecured loan from the CEO's private company (Automotive Kinetic Systems Ltd) at 12.4% interest — small ($431k) but a notable governance datapoint given the CEO/COO also own 10% of the Mexico subsidiary directly.
• Customer concentration (~77% top-3) and customer credit risk (Marelli in Chapter 11).
• Cyclical end-market (autos) with reduced OEM production plans and Chinese EV competitors pressuring legacy customers.

Earnings vs. expectations

Across the reviewed period the delivery record is mixed. FY22 was materially loss-making (~$14.5m adj loss on revenue of $124.3m) on Covid China lockdowns and supply-chain disruption. FY23 delivered a strong recovery to $8.3m adj PBT — broadly in line with the FY22 profit warning trajectory. FY24 initially reported adj PBT of $8.7m against a company-flagged consensus in the $8.5–9.0m range (an in-line result), later restated down to $7.9m. FY25 reported adj PBT of $9.5m against company-referenced market expectations of $10.5m — a modest miss, but reported PBT and EPS both grew ~20%+. The Feb 2026 trading update pre-announced FY25 revenue of "at least $113m" and adj PBT of "at least $10.0m", again a small step down from the $10.5m consensus. The 4 August 2026 H1 26 warning ("materially below" prior-year underlying PBT) is the most negative datapoint. Pattern: revenues broadly meet, profits tend to come in modestly below the point-estimate consensus, with a genuine profit warning in H1 26. This is a "just-below" record rather than either a serial beat or a serial miss.

Conviction

Conviction: 3 (moderate). Anchored by (i) a fair-value approach — forward multiple on guided PBT/EBITDA — that is well suited to a manufacturing business at this scale; (ii) triangulation across two independent methodologies (EBITDA multiple net of debt and PBT multiple) that give overlapping outputs; and (iii) explicit company guidance to consensus for FY26 that provides a near-term anchor. Limited by (i) the FY25 retrospective restatements which raise a genuine question about the historical earnings baseline off which the multiples are being applied, and (ii) the H1 26 profit shortfall which puts the FY26 guidance itself in some doubt. If earnings quality proves durable the shares are clearly cheap; if further restatements or a FY26 miss emerges the fair value shifts lower.